SPHK2 and Miyoshi myopathy: To investigate the prognostic significance of SK2 overexpression in MM development and progression, we evaluated SK2 gene expression in the APEX trial GEO microarray database (GSE9782) and correlated it with clinical outcomes such as progression-free survival (PFS) and overall survival (OS).